Global Pharmatech
(OTC) GBLP
Global Pharmatech Financials at a Glance
Market Cap
$20.76M
Revenue (TTM)
$227.70K
Net Income (TTM)
$17.67K
EPS (TTM)
$0.00
P/E Ratio
0.00
Dividend
$0.00
Beta (Volatility)
-0.18 (Low)
Dividend
$0.00
Beta (Volatility)
-0.18 (Low)
Price
$0.05
Volume
2,115
Open
$0.05
Price
$0.05
Volume
2,115
Open
$0.05
Previous Close
$0.05
Daily Range
$0.05 - $0.05
52-Week Range
$0.05 - $0.24
Dividend
$0.00
Beta (Volatility)
-0.18 (Low)
Price
$0.05
Volume
2,115
Open
$0.05
Previous Close
$0.05
Daily Range
$0.05 - $0.05
52-Week Range
$0.05 - $0.24
GBLP News
GBLP: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Global Pharmatech
Industry
Personal Products
Sector
Consumer StaplesEmployees
1
CEO
Melson Liao
Website
www.global-pharmatech.comHeadquarters
Changchun, 130 012, CN
GBLP Financials
Key Financial Metrics (TTM)
Gross Margin
21%
Operating Margin
-12%
Net Income Margin
-8%
Return on Equity
0%
Return on Capital
45%
Return on Assets
-2%
Earnings Yield
N/A
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$20.76M
Shares Outstanding
415.21M
Volume
2.12K
Short Interest
0.00%
Avg. Volume
35.25
Financials (TTM)
Gross Profit
$34.66K
Operating Income
$67.81K
EBITDA
$59.91K
Operating Cash Flow
$14.91K
Capital Expenditure
$14.91K
Free Cash Flow
$0.00
Cash & ST Invst.
$29.73K
Total Debt
$80.41K
Global Pharmatech Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$32.40K
-71.4%
Gross Profit
$19.73K
+279.0%
Gross Margin
60.88%
N/A
Market Cap
$20.76M
N/A
Market Cap/Employee
$95.67K
N/A
Employees
217
N/A
Net Income
$3.02K
+109.2%
EBITDA
$4.67K
+114.5%
Quarterly Fundamentals
Net Cash
$33.63K
+34.6%
Accounts Receivable
$330.49K
+69.9%
Inventory
$102.95K
+297.7%
Long Term Debt
$0.00
N/A
Short Term Debt
$90.58K
+12.6%
Return on Assets
-2.07%
N/A
Return on Invested Capital
45.34%
N/A
Free Cash Flow
$0.00
N/A
Operating Cash Flow
$20.89K
+87.4%